FranΓ§aisπ See the interactive version (live chart) β
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $4,336 | +334% |
| 3 years ago (2023) | $2,010 | +101% |
| 5 years ago (2021) | $1,062 | +6% |
| 10 years ago (2016) | $13,254 | +1225% |
| since 1994 | $45.60 | -95% |
| Year | Year's return | $1,000 invested at year start β worth today |
|---|---|---|
| 2026 (YTD) | +23% | $1,228 (+23%) |
| 2025 | +253% | $4,336 (+334%) |
| 2024 | -39% | $2,664 (+166%) |
| 2023 | -25% | $2,010 (+101%) |
| 2022 | -39% | $1,229 (+23%) |
| 2021 | -14% | $1,062 (+6%) |
| 2020 | +21% | $1,285 (+29%) |
| 2019 | +411% | $6,563 (+556%) |
| 2018 | +238% | $22,149 (+2115%) |
| 2017 | +137% | $52,587 (+5159%) |
| 2016 | -75% | $13,254 (+1225%) |
π See the analyst analysis of Arrowhead Pharmaceuticals β
$1000 invested in Arrowhead Pharmaceuticals 5 years ago would be worth $1,062 today, and $13,254 over 10 years (price return, excluding dividends).
Calendar-year returns β 2024: -39%. 2025: +253%. 2026: +23%. Full breakdown in the table above.
Over 10 years, Arrowhead Pharmaceuticals's average annual return (CAGR) is about 29% per year, and 1%/yr over 5 years.
Best year: 2019 (+411%). Worst year: 2016 (-75%).
It's proportional β just multiply. Over 5 years, $1,000 invested in Arrowhead Pharmaceuticals is worth $1,062, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.